fluconazole has been researched along with Esophagitis in 62 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Esophagitis: INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to assess the role and the therapeutic efficacy of 2 azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically diagnosed Candida esophagitis in patients with acquired immunodeficiency syndrome (AIDS)." | 9.08 | Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "To assess the role and the therapeutic efficacy of fluconazole and itraconazole-flucytosine association compared with placebo, in the treatment of endoscopically diagnosed esophageal candidiasis in a selected population of AIDS patients." | 9.08 | Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1996) |
| "Fluconazole and itraconazole are provided with good long-term therapeutic efficacy in the treatment of Candida esophagitis in patients with AIDS." | 9.08 | Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis. ( Alcini, P; Barbarini, G; Barbaro, G; Calderon, W; Di Lorenzo, G; Grisorio, B, 1996) |
| "The aim of this study was to assess the role and therapeutic efficacy of two azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically-diagnosed Candida oesophagitis in patients with Acquired Immunodeficiency Syndrome (AIDS)." | 9.08 | Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbaro, G; Di Lorenzo, G, 1995) |
| "The aim of the study was to assess the effectiveness of a single-dose fluconazole treatment of fungal esophagitis in patients with alcoholic liver disease." | 9.08 | Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease. ( Horváth, Z; Makara, M; Péter, Z; Telegdy, L; Zágoni, T; Zala, J, 1996) |
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 9.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "To determine the clinical and endoscopic response of candida esophagitis to antifungal therapy and to compare the two oral antifungal agents, fluconazole and ketoconazole." | 9.07 | Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. ( Conteas, CN; Dretler, RH; Islam, MZ; Koster, FM; Laine, L; Sattler, F; Squires, K; Tuazon, C, 1992) |
| "The efficacy and safety of fluconazole in the treatment of oesophageal candidiasis in patients with the acquired immunodeficiency syndrome (AIDS) was assessed in 36 patients." | 9.07 | Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. ( Dupla, ML; García-Puig, J; Gil, A; Khamashta, MA; Lavilla, P; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1991) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 9.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "Although fluconazole is increasingly utilized for the therapy of Candida oesophagitis in patients with AIDS, the time course of response has not been adequately defined." | 7.69 | Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS. ( Wilcox, CM, 1994) |
| "The efficacy and safety of fluconazole, a new triazole antifungal agent, was evaluated in 24 patients with neutropenia due to cytotoxic anticancer chemotherapy with polyfactorial immunodepression." | 7.68 | Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients. ( Blahova, M; Fuchsberger, P; Hornikova, M; Koza, I; Krcméry, V; Mardiak, J; Migom, C; Savko, V; Spanik, S; Sufliarsky, J, 1991) |
| "We have reviewed the efficacy of the use of fluconazole in patients with definitely proven Candida esophagitis (CE) associated with human immunodeficiency virus (HIV) infection, using a single 400 mg oral dose of fluconazole and evaluating the patient three days afterwards." | 7.68 | [Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases]. ( Carrasco, R; Martínez, A; Medina, E; Navarro, V; Nieto, A; Roig, P; Salavert, M, 1990) |
| "Candida esophagitis was suspected." | 5.43 | Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report. ( Chen, KH; Chou, YH; Hsieh, CH; Lu, YF; Weng, MT, 2016) |
| "No differences in efficacy or safety were found between fluconazole and other azoles for the treatment of candida oesophagitis." | 5.22 | Systemic antifungal therapy for oesophageal candidiasis - systematic review and meta-analysis of randomized controlled trials. ( Atamna, A; Ayada, G; Bishara, J; Margalit, I; Matsri, S; Mwassi, HA; Shargian, L; Yahav, D, 2022) |
| "The efficacy and safety of caspofungin were compared with fluconazole in adult patients with Candida esophagitis in a double-blind randomized trial." | 5.10 | A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. ( Arathoon, EG; DiNubile, MJ; Gotuzzo, E; Kartsonis, NA; Lupinacci, RJ; Noriega, LM; Sable, CA; Smietana, JM; Villanueva, A, 2002) |
| "The aim of the study was to assess the effectiveness of a single-dose fluconazole treatment of fungal esophagitis in patients with alcoholic liver disease." | 5.08 | Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease. ( Horváth, Z; Makara, M; Péter, Z; Telegdy, L; Zágoni, T; Zala, J, 1996) |
| "The aim of this study was to assess the role and the therapeutic efficacy of 2 azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically diagnosed Candida esophagitis in patients with acquired immunodeficiency syndrome (AIDS)." | 5.08 | Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "Fluconazole and itraconazole are provided with good long-term therapeutic efficacy in the treatment of Candida esophagitis in patients with AIDS." | 5.08 | Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis. ( Alcini, P; Barbarini, G; Barbaro, G; Calderon, W; Di Lorenzo, G; Grisorio, B, 1996) |
| "The aim of this study was to assess the role and therapeutic efficacy of two azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically-diagnosed Candida oesophagitis in patients with Acquired Immunodeficiency Syndrome (AIDS)." | 5.08 | Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbaro, G; Di Lorenzo, G, 1995) |
| "To assess the role and the therapeutic efficacy of fluconazole and itraconazole-flucytosine association compared with placebo, in the treatment of endoscopically diagnosed esophageal candidiasis in a selected population of AIDS patients." | 5.08 | Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1996) |
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 5.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "To determine the clinical and endoscopic response of candida esophagitis to antifungal therapy and to compare the two oral antifungal agents, fluconazole and ketoconazole." | 5.07 | Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. ( Conteas, CN; Dretler, RH; Islam, MZ; Koster, FM; Laine, L; Sattler, F; Squires, K; Tuazon, C, 1992) |
| "After the first episode of esophageal candidiasis, 122 consecutive AIDS patients were randomly assigned to two different regimens of continuous long-term antifungal prophylaxis (ketoconazole 200 mg or fluconazole 50 mg/day p." | 5.07 | Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. ( Antinori, S; Ardizzone, S; Bianchi Porro, G; Cernuschi, M; Esposito, R; Lazzarin, A; Moroni, M; Parente, F, 1994) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 5.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "The efficacy and safety of fluconazole in the treatment of oesophageal candidiasis in patients with the acquired immunodeficiency syndrome (AIDS) was assessed in 36 patients." | 5.07 | Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. ( Dupla, ML; García-Puig, J; Gil, A; Khamashta, MA; Lavilla, P; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1991) |
| "After antifungal treatment with fluconazole, the patient's clinical symptoms gradually disappeared with the healing of gastric ulcer, which never recurred in this patient until 3 months after follow-up." | 3.91 | A rare case report of fungal esophagitis combined with giant gastric ulcer in an immunocompetent patient. ( Jianping, C; Juan, D; Liang, M; Liwen, Z; Yanbo, D; Yun, Z, 2019) |
| "Although fluconazole is increasingly utilized for the therapy of Candida oesophagitis in patients with AIDS, the time course of response has not been adequately defined." | 3.69 | Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS. ( Wilcox, CM, 1994) |
| "The efficacy and safety of fluconazole, a new triazole antifungal agent, was evaluated in 24 patients with neutropenia due to cytotoxic anticancer chemotherapy with polyfactorial immunodepression." | 3.68 | Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients. ( Blahova, M; Fuchsberger, P; Hornikova, M; Koza, I; Krcméry, V; Mardiak, J; Migom, C; Savko, V; Spanik, S; Sufliarsky, J, 1991) |
| "We have reviewed the efficacy of the use of fluconazole in patients with definitely proven Candida esophagitis (CE) associated with human immunodeficiency virus (HIV) infection, using a single 400 mg oral dose of fluconazole and evaluating the patient three days afterwards." | 3.68 | [Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases]. ( Carrasco, R; Martínez, A; Medina, E; Navarro, V; Nieto, A; Roig, P; Salavert, M, 1990) |
| "Clinical evaluation of fluconazole was performed on 12 cases of mycotic infections (7 cases of Candida esophagitis; one each case of cryptococcal meningitis with AIDS, Candida tropicalis fungemia and disseminated cryptococcosis in kidney transplant patient; 2 cases of Candida pneumonia)." | 3.67 | [Clinical evaluation of fluconazole]. ( Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M, 1989) |
| "When mycoses are diagnosed early and treated with the appropriate drugs, favorable therapeutic outcomes can be achieved." | 1.72 | Fungal esophagitis associated with tuberculous pericarditis in an human immunodeficiency virus-positive patient: a case report. ( de Lima-Neto, RG; de Melo, HRL; de Sousa, BR; Neves, RP; Silva, GM; Torres, KB, 2022) |
| "Esophageal candidiasis is the most frequent form of esophagitis." | 1.62 | Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis. ( Gharaghani, M; Jafarian, H; Mahmoudabadi, AZ; Seyedian, SS, 2021) |
| "Candida esophagitis was suspected." | 1.43 | Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report. ( Chen, KH; Chou, YH; Hsieh, CH; Lu, YF; Weng, MT, 2016) |
| "The fungal esophagitis in patients with hematologic malignancies was not rare." | 1.43 | [A clinical study of fungal esophagitis in 13 patients with hematologic malignancies]. ( Ai, H; Li, YF; Liu, YY; Mi, RH; Song, YP; Wei, XD; Zhang, LN; Zhou, YL, 2016) |
| "Although infective esophagitis is encountered sporadically in pediatric age group, but it should always be considered in high risk individuals and when conventional medication fails to resolve the symptoms." | 1.43 | Fungal Esophagitis in a Child with Insulin Dependent Diabetes Mellitus. ( Alsheikh, A; Assiri, A; Saeed, A; Zaidi, Z, 2016) |
| "Saccharomyces oesophagitis is a rare condition which has been described so far in only two publications." | 1.37 | Saccharomyces cerevisiae oesophagitis in a patient with oesophageal carcinoma. ( Antonello, VS; Kliemann, DA; Pasqualotto, AC; Severo, LC, 2011) |
| "Oesophageal candidiasis is an epithelial infection which requires an immune deficiency." | 1.33 | [Oesophageal candidiasis: clinical and mycological analysis]. ( Araya, V; Cahn, P; Concetti, H; Guelfand, L; Kaufman, S; Olmos, MA; Pérez, H; Piskorz, E; Ramallo, J, 2005) |
| "Case 2 was a boy with candida pneumonitis." | 1.29 | [Fluconazole therapy for pediatric patients with severe candidal infections]. ( Hisakawa, H; Kurashige, T; Misaki, Y; Morita, H; Okada, T; Sinohara, M; Tomoda, T; Wakiguchi, H; Watanabe, S, 1994) |
| "esophagitis is common in HIV-infected patients." | 1.28 | Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. ( Aguado, AG; Khamashta, MA; López-Dupla, M; Mora Sanz, P; Pintado García, V; Uriol, PL; Valencia Ortega, E, 1992) |
| "We conclude that most AIDS patients with dysphagia/odynophagia who do not respond to oral antifungals have an opportunistic infection of the esophagus." | 1.28 | Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. ( Bianchi Porro, G; Cernuschi, M; Lazzarin, A; Parente, F; Rizzardini, G; Valsecchi, L, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.61) | 18.7374 |
| 1990's | 33 (53.23) | 18.2507 |
| 2000's | 12 (19.35) | 29.6817 |
| 2010's | 11 (17.74) | 24.3611 |
| 2020's | 5 (8.06) | 2.80 |
| Authors | Studies |
|---|---|
| López Peña, C | 1 |
| Barrientos Delgado, A | 1 |
| Soler Góngora, M | 1 |
| Mwassi, HA | 1 |
| Yahav, D | 1 |
| Ayada, G | 1 |
| Matsri, S | 1 |
| Margalit, I | 1 |
| Shargian, L | 1 |
| Bishara, J | 1 |
| Atamna, A | 1 |
| Sousa, BR | 1 |
| Freitas, JF | 1 |
| Valeriano, CA | 1 |
| Neto, LN | 1 |
| Neves, RP | 3 |
| Gambarra, FF | 1 |
| Gomes, TM | 1 |
| da Silva Acioly, JC | 1 |
| Lima-Neto, RG | 1 |
| Silva, GM | 1 |
| de Sousa, BR | 1 |
| Torres, KB | 1 |
| de Melo, HRL | 1 |
| de Lima-Neto, RG | 1 |
| Bamidele, OF | 1 |
| Olokoba, AB | 1 |
| Bojuwoye, MO | 1 |
| Barde, AA | 1 |
| Jafarian, H | 1 |
| Gharaghani, M | 1 |
| Seyedian, SS | 1 |
| Mahmoudabadi, AZ | 1 |
| Furukawa, D | 1 |
| Ohtani, K | 1 |
| Kawahara, T | 1 |
| Yakabe, D | 1 |
| Tsutsui, H | 1 |
| Liang, M | 1 |
| Liwen, Z | 1 |
| Juan, D | 1 |
| Yun, Z | 1 |
| Yanbo, D | 1 |
| Jianping, C | 1 |
| Chen, KH | 1 |
| Weng, MT | 1 |
| Chou, YH | 1 |
| Lu, YF | 1 |
| Hsieh, CH | 1 |
| Zhou, YL | 1 |
| Wei, XD | 1 |
| Mi, RH | 1 |
| Ai, H | 1 |
| Zhang, LN | 1 |
| Liu, YY | 1 |
| Li, YF | 1 |
| Song, YP | 1 |
| Saeed, A | 1 |
| Assiri, A | 1 |
| Zaidi, Z | 1 |
| Alsheikh, A | 1 |
| Kumar, S | 1 |
| Minz, M | 1 |
| Sinha, SK | 1 |
| Vaiphei, K | 1 |
| Sharma, A | 1 |
| Singh, S | 1 |
| Kenwar, DB | 1 |
| Macêdo, DP | 1 |
| Oliveira, NT | 1 |
| Farias, AM | 1 |
| Silva, VK | 1 |
| Wilheim, AB | 1 |
| Couto, FM | 1 |
| Hyun, JJ | 1 |
| Chun, HJ | 1 |
| Keum, B | 1 |
| Seo, YS | 1 |
| Kim, YS | 1 |
| Jeen, YT | 1 |
| Lee, HS | 1 |
| Um, SH | 1 |
| Kim, CD | 1 |
| Ryu, HS | 1 |
| Weingart, V | 1 |
| Allescher, HD | 1 |
| Kliemann, DA | 1 |
| Antonello, VS | 1 |
| Severo, LC | 1 |
| Pasqualotto, AC | 1 |
| Villanueva, A | 1 |
| Gotuzzo, E | 1 |
| Arathoon, EG | 1 |
| Noriega, LM | 1 |
| Kartsonis, NA | 1 |
| Lupinacci, RJ | 1 |
| Smietana, JM | 1 |
| DiNubile, MJ | 1 |
| Sable, CA | 1 |
| Nuevo, JA | 1 |
| Hijano, A | 1 |
| Eimil, M | 1 |
| Valdivia, A | 1 |
| Candel, FJ | 1 |
| Núñez, MJ | 1 |
| Roca, V | 1 |
| Jiménez-Alonso, J | 1 |
| Estev, D | 1 |
| Vera, C | 1 |
| Sabio, JM | 1 |
| Zaidi, SA | 1 |
| Cervia, JS | 1 |
| Bernhardt, J | 1 |
| Bernhardt, H | 1 |
| Knoke, M | 1 |
| Ludwig, K | 1 |
| Rahhal, RM | 1 |
| Ramkumar, DP | 1 |
| Pashankar, DS | 1 |
| Brncić, N | 1 |
| Mijandrusić-Sincić, B | 1 |
| Visković, I | 1 |
| Olmos, MA | 1 |
| Araya, V | 1 |
| Concetti, H | 1 |
| Ramallo, J | 1 |
| Piskorz, E | 1 |
| Pérez, H | 1 |
| Cahn, P | 1 |
| Kaufman, S | 1 |
| Guelfand, L | 1 |
| Chen, LI | 1 |
| Chang, JM | 1 |
| Kuo, MC | 1 |
| Hwang, SJ | 1 |
| Chen, HC | 1 |
| Kurnatowska, I | 1 |
| Pazurek, M | 1 |
| Nowicki, M | 1 |
| Barbaro, G | 5 |
| Barbarini, G | 4 |
| Di Lorenzo, G | 5 |
| Wilcox, CM | 2 |
| Parente, F | 2 |
| Ardizzone, S | 1 |
| Cernuschi, M | 2 |
| Antinori, S | 1 |
| Esposito, R | 1 |
| Moroni, M | 1 |
| Lazzarin, A | 2 |
| Bianchi Porro, G | 2 |
| Wakiguchi, H | 1 |
| Hisakawa, H | 1 |
| Sinohara, M | 1 |
| Watanabe, S | 1 |
| Okada, T | 1 |
| Misaki, Y | 1 |
| Tomoda, T | 1 |
| Morita, H | 1 |
| Kurashige, T | 1 |
| Neely, D | 1 |
| Diz, P | 1 |
| Ocampo, A | 1 |
| Miralles, C | 1 |
| Otero, I | 1 |
| Iglesias, I | 1 |
| Martínez, C | 1 |
| Legg, JJ | 1 |
| Brossier, KA | 1 |
| Goldschmidt, RH | 1 |
| Thio, CL | 1 |
| Rutledge, TM | 1 |
| Ng, TT | 1 |
| Denning, DW | 1 |
| Maenza, JR | 1 |
| Keruly, JC | 1 |
| Moore, RD | 1 |
| Chaisson, RE | 1 |
| Merz, WG | 1 |
| Gallant, JE | 1 |
| Braegger, CP | 1 |
| Albisetti, M | 1 |
| Nadal, D | 1 |
| Ganatra, JV | 1 |
| Bostwick, HE | 1 |
| Medow, MS | 1 |
| Beneck, D | 1 |
| Berezin, S | 1 |
| Eichel, M | 1 |
| Just-Nübling, G | 1 |
| Helm, EB | 1 |
| Stille, W | 1 |
| Péter, Z | 1 |
| Horváth, Z | 1 |
| Makara, M | 1 |
| Telegdy, L | 1 |
| Zala, J | 1 |
| Zágoni, T | 1 |
| Le, TP | 1 |
| Tuazon, CU | 1 |
| Levine, M | 1 |
| Borum, M | 1 |
| Rollhauser, C | 1 |
| Bode, CP | 1 |
| Schroten, H | 1 |
| Koletzko, S | 1 |
| Lübke, H | 1 |
| Wahn, V | 1 |
| Calderon, W | 1 |
| Grisorio, B | 1 |
| Alcini, P | 1 |
| Alexander, LN | 1 |
| Clark, WS | 1 |
| Thompson, SE | 1 |
| Shapiro, BD | 1 |
| Ehrenpreis, ED | 1 |
| Tomaka, FL | 1 |
| Bonner, GF | 1 |
| Secrest, KM | 1 |
| Cheney, LM | 1 |
| Ustianowski, AP | 1 |
| Leake, H | 1 |
| Evans, S | 1 |
| Breidert, M | 1 |
| Schimmelpfennig, C | 1 |
| Kittner, T | 1 |
| Helwig, A | 1 |
| Ehninger, G | 1 |
| Fichtenbaum, CJ | 1 |
| Koletar, S | 1 |
| Yiannoutsos, C | 1 |
| Holland, F | 1 |
| Pottage, J | 1 |
| Cohn, SE | 1 |
| Walawander, A | 1 |
| Frame, P | 1 |
| Feinberg, J | 1 |
| Saag, M | 1 |
| Van der Horst, C | 1 |
| Powderly, WG | 1 |
| Laine, L | 1 |
| Dretler, RH | 1 |
| Conteas, CN | 1 |
| Tuazon, C | 1 |
| Koster, FM | 1 |
| Sattler, F | 1 |
| Squires, K | 1 |
| Islam, MZ | 1 |
| López-Dupla, M | 1 |
| Mora Sanz, P | 1 |
| Pintado García, V | 1 |
| Valencia Ortega, E | 1 |
| Uriol, PL | 1 |
| Khamashta, MA | 2 |
| Aguado, AG | 1 |
| Dronda, F | 1 |
| Rodríguez-Tudela, JL | 1 |
| Mera, P | 1 |
| Martínez-Suárez, J | 1 |
| Krcméry, V | 1 |
| Koza, I | 1 |
| Hornikova, M | 1 |
| Fuchsberger, P | 1 |
| Spanik, S | 1 |
| Mardiak, J | 1 |
| Sufliarsky, J | 1 |
| Blahova, M | 1 |
| Savko, V | 1 |
| Migom, C | 1 |
| Brockmeyer, NH | 1 |
| Hantschke, D | 1 |
| Olbricht, T | 1 |
| Hengge, UA | 1 |
| Goos, M | 1 |
| De Wit, S | 1 |
| Urbain, D | 1 |
| Rahir, F | 1 |
| Weerts, D | 1 |
| Clumeck, N | 1 |
| Gil, A | 1 |
| Lavilla, P | 1 |
| Valencia, E | 1 |
| Pintado, V | 1 |
| Dupla, ML | 1 |
| García-Puig, J | 1 |
| Ortiz-Vázquez, J | 1 |
| Rizzardini, G | 1 |
| Valsecchi, L | 1 |
| Roig, P | 1 |
| Martínez, A | 1 |
| Salavert, M | 1 |
| Nieto, A | 1 |
| Navarro, V | 1 |
| Medina, E | 1 |
| Carrasco, R | 1 |
| Heise, W | 1 |
| Arasteh, K | 1 |
| L'age, M | 1 |
| Oka, S | 1 |
| Tokitsu, M | 1 |
| Mori, H | 1 |
| Nakata, H | 1 |
| Goto, M | 1 |
| Goto, H | 1 |
| Shimada, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PROCAS: Study Observational Prospective and Multicenter to Determine the Clinic Effectiveness and the Safety of Caspofungin Acetate (CANCIDAS®) in the Treatment of Invader Fungal Infection[NCT00388167] | 320 participants (Anticipated) | Observational | 2004-03-31 | Completed | |||
| Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.[NCT00002132] | 0 participants | Interventional | Completed | ||||
| A Randomized Comparative Multicenter Trial of Fluconazole and Ketoconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients[NCT00002304] | 0 participants | Interventional | Completed | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for fluconazole and Esophagitis
| Article | Year |
|---|---|
Systemic antifungal therapy for oesophageal candidiasis - systematic review and meta-analysis of randomized controlled trials.
Topics: Antifungal Agents; Azoles; Candidiasis; Echinocandins; Esophagitis; Fluconazole; Humans; Randomized | 2022 |
Refractory esophagitis caused by
Topics: Adult; Antifungal Agents; Brazil; Drug Resistance, Fungal; Esophagitis; Fluconazole; HIV Infections; | 2022 |
[Non-cardiac chest pain].
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Antifungal Agents; Candidiasis; Chest Pain; Diagnosi | 2010 |
Diagnosis and management of infectious esophagitis associated with human immunodeficiency virus infection.
Topics: AIDS-Related Opportunistic Infections; Antibiotic Prophylaxis; Antifungal Agents; Diagnosis, Differe | 2002 |
Combined herpes viral and candidal esophagitis in a CAPD patient: case report and review of literature.
Topics: Acyclovir; Antifungal Agents; Antiviral Agents; Candidiasis; Esophagitis; Fatal Outcome; Female; Flu | 2007 |
Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach.
Topics: AIDS-Related Opportunistic Infections; Candida; Candidiasis; Candidiasis, Oral; Drug Resistance, Mic | 1993 |
13 trials available for fluconazole and Esophagitis
| Article | Year |
|---|---|
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Ag | 2002 |
Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1995 |
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Esophagitis; Female; Fluconazole; Follow- | 1994 |
Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1995 |
Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Confidence Intervals; | 1995 |
Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease.
Topics: Adult; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Drug Administration Schedul | 1996 |
Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Esophagitis; Female; F | 1996 |
Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms.
Topics: Adult; Antifungal Agents; Candidiasis; Cost-Benefit Analysis; Esophageal Diseases; Esophagitis; Esop | 1996 |
Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; | 1996 |
Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidia | 2000 |
Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Double-Blind Method; Esophagitis; Esophagosc | 1992 |
Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Alanine Transaminase; Asparta | 1991 |
Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Esophagitis; Female; Fluconazole; Humans; Ma | 1991 |
43 other studies available for fluconazole and Esophagitis
| Article | Year |
|---|---|
Recidivant odynophagia secondary to persistent esophageal candidiasis in an immunocompetent patient: the importance of brush cytology.
Topics: Candidiasis; Deglutition Disorders; Esophageal Diseases; Esophagitis; Female; Fluconazole; Humans; M | 2022 |
Fungal esophagitis associated with tuberculous pericarditis in an human immunodeficiency virus-positive patient: a case report.
Topics: Adult; Antifungal Agents; Candidiasis; Esophagitis; Fluconazole; HIV; Humans; Male; Mycoses; Pericar | 2022 |
Oesophageal intramural pseudodiverticulosis: a rare endoscopic finding.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Deglutition Disorders; Endoscopy, Dige | 2019 |
Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidiasis; Esopha | 2021 |
Candida oesophagitis incidentally detected by fluorine-18 fluorodeoxyglucose positron emission tomography in a patient with sarcoidosis.
Topics: Candida albicans; Candidiasis; Esophagitis; Female; Fluconazole; Fluorodeoxyglucose F18; Humans; Inc | 2017 |
A rare case report of fungal esophagitis combined with giant gastric ulcer in an immunocompetent patient.
Topics: Aged; Anti-Ulcer Agents; Antifungal Agents; Endoscopy, Gastrointestinal; Esophagitis; Fluconazole; H | 2019 |
Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Candidiasis; Carcinoma, Hepatocel | 2016 |
[A clinical study of fungal esophagitis in 13 patients with hematologic malignancies].
Topics: Esophagitis; Fluconazole; Hematologic Neoplasms; Humans; Mycoses; Prognosis; Retrospective Studies; | 2016 |
Fungal Esophagitis in a Child with Insulin Dependent Diabetes Mellitus.
Topics: Abdominal Pain; Antifungal Agents; Biopsy; Candida; Candidiasis; Child; Diabetes Mellitus, Type 1; E | 2016 |
Esophageal tuberculosis with coexisting opportunistic infections in a renal allograft transplant recipient.
Topics: Antifungal Agents; Antitubercular Agents; Antiviral Agents; Candidiasis, Oral; Deglutition Disorders | 2017 |
Esophagitis caused by Candida guilliermondii in diabetes mellitus: first reported case.
Topics: Antifungal Agents; Candida; Candidiasis; Diabetes Complications; DNA, Fungal; DNA, Ribosomal; Esopha | 2010 |
Candida esophagitis complicated by esophageal stricture.
Topics: Adult; Antifungal Agents; Candidiasis; Deglutition Disorders; Esophageal Stenosis; Esophagitis; Esop | 2010 |
Saccharomyces cerevisiae oesophagitis in a patient with oesophageal carcinoma.
Topics: Antifungal Agents; Carcinoma; Endoscopy, Digestive System; Esophageal Neoplasms; Esophagitis; Flucon | 2011 |
[Candida esophagitis in a non-immunosuppressed patient].
Topics: Adult; Antifungal Agents; Antitubercular Agents; Candidiasis; Esophagitis; Female; Fluconazole; Huma | 2002 |
Dysphagia in patients with systemic lupus erythematosus.
Topics: Candida albicans; Candidiasis; Deglutition Disorders; Esophagitis; Esophagoscopy; Female; Fluconazol | 2003 |
Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Line, Tumor; Epithelial Cells; Esophagitis; E | 2004 |
Simultaneous herpetic and candidal esophagitis in an immunocompetent teenager.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acyclovir; Adolescent; Antifungal Agents; Antiviral Agents; | 2005 |
Candida esophagitis.
Topics: Aged; Antifungal Agents; Candidiasis; Esophagitis; Fluconazole; Humans; Male | 2005 |
[Oesophageal candidiasis: clinical and mycological analysis].
Topics: Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Esophagitis; E | 2005 |
Case of esophagitis in a posttransplant female patient.
Topics: Antifungal Agents; Candidiasis; Esophagitis; Female; Fluconazole; Humans; Immunocompromised Host; Ki | 2007 |
Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candidiasis; Drug Administration Sc | 1994 |
[Fluconazole therapy for pediatric patients with severe candidal infections].
Topics: Adolescent; Candidiasis; Child; Esophagitis; Female; Fluconazole; Humans; Lung Diseases, Fungal; Mal | 1994 |
Cost-effective treatment of Candida esophagitis.
Topics: Candidiasis; Esophagitis; Fluconazole; Humans; Ketoconazole | 1993 |
[Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Drug Resistance, Micro | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: Candidiasis; Esophagitis; Fluconazole; Humans; Ketoconazole | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: Candidiasis; Drug Costs; Esophagitis; Fluconazole; Humans; Ketoconazole | 1993 |
Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Case-Co | 1996 |
Extensive esophageal candidiasis in the absence of oral lesions in pediatric AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidia | 1995 |
Candida esophagitis in a child with achalasia.
Topics: Antifungal Agents; Candidiasis; Child; Esophageal Achalasia; Esophagitis; Esophagus; Fluconazole; Hu | 1996 |
[Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Ca | 1996 |
Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1996 |
Transient achalasia-like esophageal motility disorder after candida esophagitis in a boy with chronic granulomatous disease.
Topics: Adolescent; Candidiasis; Cytochrome b Group; Esophageal Achalasia; Esophagitis; Fluconazole; Genetic | 1996 |
Idiopathic midesophageal stricture: a new cause of dysphagia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Candidiasis; Deglutition Disorders; Esophageal St | 1997 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidias | 1997 |
Diabetes insipidus in a patient with a highly malignant B-cell lymphoma and stomatitis.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasis, Oral; Cycloph | 2000 |
Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases.
Topics: Biopsy; Candidiasis; Candidiasis, Oral; CD4-CD8 Ratio; Drug Administration Schedule; Esophagitis; Es | 1992 |
[Esophagitis caused by fluconazole-resistant Candida albicans: therapeutic failure and in vitro correlation].
Topics: Adult; Candida albicans; Drug Resistance, Microbial; Esophagitis; Fluconazole; Humans; Male | 1992 |
Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Candidiasis, Oral; Drug Evaluation; Esophagitis; | 1991 |
[Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Esophagitis; Female; Fluconazole; Flucytosin | 1991 |
Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Oral; Adult; Amphotericin B; Antifung | 1991 |
[Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases].
Topics: Adult; Candidiasis; Esophagitis; Female; Fluconazole; HIV Infections; Humans; Male; Prospective Stud | 1990 |
[The therapy of Candida esophagitis in AIDS patients with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Esophagitis; Esophagoscopy; Fluconazole; Humans; Op | 1990 |
[Clinical evaluation of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Funga | 1989 |